
What the First FDA-Cleared LLM Actually Does
The FDA just cleared its first patient-facing generative AI tool, but the algorithm is not the one writing your prescription.
Discover the newest research about AI innovations in 🧠Digital Therapeutics.

The FDA just cleared its first patient-facing generative AI tool, but the algorithm is not the one writing your prescription.

The regulatory approval of a non-invasive brain stimulation headset for PTSD exposes a massive, decades-long stagnation in psychiatric drug development.

A national health system is handing its musculoskeletal care over to algorithms, setting up a massive test case for automated medicine.

A delayed regulatory nod puts Boston Scientific’s multi-billion-dollar bet to the test.

Algorithms can now recommend insulin doses as safely as human specialists, shifting the bottleneck of diabetes care from clinical expertise to patient trust.

A massive new funding round proves that health systems are ready to delegate daily clinical tasks to supervised AI agents.

A routine test that costs pennies can now spot hidden heart failures before symptoms even appear.

The regulatory bottleneck for AI in drug development is finally beginning to crack.

A smartphone camera might soon replace the physical throat swab, shifting the front line of infectious disease diagnosis from the clinic to the palm of your hand.

TEC data is reshaping adult social care, enhancing decision-making and prevention strategies. Councils must prioritize workforce training for effective implementation. 📊👥